¾ÅÓÎÌåÓý

Health Observance

Cholesterol Education Month 2021

Research highlights: genes, bears and bugs (of the viral variety)
Courtney Chandler
Sept. 1, 2021

While cholesterol may have a bad rep, it is necessary for human health — it gives your body the building blocks it needs to make cells, hormones and vitamins. Cholesterol becomes a problem when there's too much of it circulating in your bloodstream. As cholesterol levels increase, so does the risk for developing diseases such as heart disease and stroke, two leading causes of death in the U.S.

Around 10% of adults in the U.S. have high total cholesterol levels. Much research has focused on better understanding how cholesterol is made and trafficked in our body, oftentimes with the goal of developing better diagnostic tools and treatments to prevent disease. Here, I’ve rounded up some of the most recent research on cholesterol in honor of Cholesterol Education Month.

Gene variants that impair cholesterol clearance

High density lipoprotein and its primary receptor, called scavenger receptor class B type I, or SR-BI, work together to clear excess cholesterol from the bloodstream, thus protecting against fatty plaque buildup in the arteries. Humans have different genetic variants of SR-BI, some of which have been identified in patients with high levels of HDL and cholesterol. Researchers from Medical College of Wisconsin recently their work on a specific SR-BI variant associated with cardiovascular disease in the Journal of Lipid Research. They found that this variant, which has a cysteine residue at amino acid position 174 instead of an arginine and is thus called R174C-SR-BI, had impaired cholesterol transport in monkey cells. If these results translate to humans, this variant could be a risk factor for impaired cholesterol clearance and cardiovascular disease. Genetic screening may help physicians better identify patients with this variant and develop better treatment plans.

What bears can tell us about cholesterol

Recent insights into cholesterol research focused on an unexpected group of fuzzy animals — bears. Specifically, Swedish brown bears. Earlier this year, ASBMB Today's Arti Dumbrepatil wrote about how a team of researchers compared human and bear lipoproteins to try to understand why hibernating bears can withstand elevated levels of cholesterol and triglycerides without developing clogged arteries, whereas humans can’t. , also published in the Journal of Lipid Research, found that bear lipoproteins differ in structure and function, which results in less binding to the walls of arteries and thus less fatty plaque buildup. To learn more, read Dumbrepatil's article.

Reducing cholesterol to block viruses

While cholesterol may be important for our health, it’s also important for the life cycle of other, more nefarious entities. Some types of viruses, called enveloped viruses, emerge from infected human cells in cholesterol-rich lipid rafts. (SARS-CoV-2 is an enveloped virus.) Lowering the levels of cellular cholesterol can impede this process, reducing the ability of these viruses to spread and survive. Researchers from the University of Michigan recently described how an enzyme located to the endoplasmic reticulum, called viperin, exerts its antiviral effects by downregulating cholesterol biosynthesis. After expression, viperin forms a complex with key cholesterol biosynthesis enzymes lanosterol synthetase and squalene monooxygenase. Formation of this complex correlates with a reduction in total cellular cholesterol, possibly through inhibition of those key enzymes, thus preventing of viral budding. This research, in the Journal of Biological Chemistry, points to control of cholesterol biosynthesis as a means for cells to protect themselves against enveloped viruses. 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a careers columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Neurobiology of stress and substance use
Profile

Neurobiology of stress and substance use

June 19, 2025

MOSAIC scholar and proud Latino, Bryan Cruz of Scripps Research Institute studies the neurochemical origins of PTSD-related alcohol use using a multidisciplinary approach.

Pesticide disrupts neuronal potentiation
Journal News

Pesticide disrupts neuronal potentiation

June 17, 2025

New research reveals how deltamethrin may disrupt brain development by altering the protein cargo of brain-derived extracellular vesicles. Read more about this recent Molecular & Cellular Proteomics article.

A look into the rice glycoproteome
Journal News

A look into the rice glycoproteome

June 17, 2025

Researchers mapped posttranslational modifications in Oryza sativa, revealing hundreds of alterations tied to key plant processes. Read more about this recent Molecular & Cellular Proteomics paper.

Proteomic variation in heart tissues
Journal News

Proteomic variation in heart tissues

June 17, 2025

By tracking protein changes in stem cell–derived heart cells, researchers from Cedars-Sinai uncovered surprising diversity — including a potential new cell type — that could reshape how we study and treat heart disease.

Parsing plant pigment pathways
Webinar

Parsing plant pigment pathways

June 13, 2025

Erich Grotewold of Michigan State University, an ASBMB Breakthroughs speaker, discusses his work on the genetic regulation of flavonoid biosynthesis.

Calcium channel linked to cancer drug resistance
Journal News

Calcium channel linked to cancer drug resistance

June 12, 2025

Researchers discover a protein associated with carboplatin-resistant retinoblastoma, suggesting this protein could be a promising therapeutic target. Read more about this recent Journal of Biological Chemistry paper.